Raymond Pratt
Director Técnico/Científico/I+D en SAVARA INC. .
Fortuna: 44 500 $ al 30/04/2024
Perfil
Raymond D.
Pratt is an Independent Director at XORTX Therapeutics, Inc. and the Chief Medical Officer at Savara, Inc. He previously worked as the Assistant Chief & Director-Dialysis Services at Walter Reed Army Medical Center, Senior Director-Clinical Research & Development at Eisai Medical Research, Inc., Vice President-Strategic Drug Development at Quintiles Transnational Corp., Chief Development Officer at Rockwell Medical, Inc., Vice President-Research & Development at Shire Plc and Shire Pharmaceutical Development, Inc., and Assistant Professor at Weill Cornell Medical College and The Johns Hopkins University School of Medicine.
Pratt holds a doctorate degree from the University of Illinois College of Medicine.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SAVARA, INC.
0.01% | 08/04/2024 | 10 000 ( 0.01% ) | 44 500 $ | 30/04/2024 |
XORTX THERAPEUTICS, INC.
-.--% | 04/03/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Cargos activos de Raymond Pratt
| Empresas | Cargo | Inicio |
|---|---|---|
| XORTX THERAPEUTICS INC. | Director/Miembro de la Junta | 20/12/2021 |
| SAVARA INC. | Director Técnico/Científico/I+D | 10/11/2022 |
Antiguos cargos conocidos de Raymond Pratt.
| Empresas | Cargo | Fin |
|---|---|---|
| ROCKWELL MEDICAL, INC. | Director Técnico/Científico/I+D | 20/11/2019 |
Quintiles Transnational Corp.
 Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Corporate Officer/Principal | 01/01/2012 |
| SHIRE | Director de Operaciones | 01/01/2010 |
Shire Pharmaceutical Development, Inc.
 Shire Pharmaceutical Development, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceutical Development, Inc. engages in research and development of pharmaceutical drugs. It develops drugs for the treatment of metachromatic leukodystrophy, hereditary angioedema, hunter syndrome, and gaucher diseases. The company was founded in 2000 and is headquartered in Rockville. MD. | Director Técnico/Científico/I+D | 01/01/2010 |
| Eisai Medical Research, Inc. | Director Técnico/Científico/I+D | 01/01/2003 |
Formación de Raymond Pratt.
| University of Illinois College of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| ROCKWELL MEDICAL, INC. | Health Technology |
| XORTX THERAPEUTICS INC. | Health Technology |
| SAVARA INC. | Health Technology |
| Empresas privadas | 5 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
| Eisai Medical Research, Inc. | |
| Walter Reed Army Medical Center | |
Quintiles Transnational Corp.
Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Commercial Services |
Shire Pharmaceutical Development, Inc.
Shire Pharmaceutical Development, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceutical Development, Inc. engages in research and development of pharmaceutical drugs. It develops drugs for the treatment of metachromatic leukodystrophy, hereditary angioedema, hunter syndrome, and gaucher diseases. The company was founded in 2000 and is headquartered in Rockville. MD. | Health Technology |
- Bolsa de valores
- Insiders
- Raymond Pratt